![]() Fresh Tracks Therapeutics Fresh Tracks Therapeutics (formerly known as Brickell Biotech) is a clinical-stage pharmaceutical company focused on the development of innovative and differentiated therapeutics for the treatment of skin diseases. | |||
Founding Date | Founding Date 2009 | Founding Date 2003 | Founding Date 2009 |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations South San Francisco, US HQ | Locations Wien, AT HQ | Locations Boulder, US HQ Carmel, US |
Employees | Employees 98 | Employees 3 | Employees 1338% decrease |
Valuation ($) | Valuation ($) 23.6 m | Valuation ($) N/A | Valuation ($) 4.3 m |
Financial | |||
Net income | Net income ($26m) (FY, 2024) | Net income N/A | Net income ($5.7m) (FY, 2023) |
Funding | |||
Total funding raised | Total funding raised $ 210.6m | Total funding raised $ 34.1m | Total funding raised $ 25.4m |

AFFiRiS is a company that delivers therapies to patients with neurodegenerative diseases.
View company
Fresh Tracks Therapeutics (formerly known as Brickell Biotech) is a clinical-stage pharmaceutical company focused on the development of innovative and differentiated therapeutics for the treatment of skin diseases.
View company